134 related articles for article (PubMed ID: 27113542)
1. Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.
Qin Z; Wang P; Li X; Zhang S; Tian M; Dai Y; Fu L
Mol Biosyst; 2016 Jun; 12(7):2108-18. PubMed ID: 27113542
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
[TBL] [Abstract][Full Text] [Related]
3. A Single Kinase Generates the Majority of the Secreted Phosphoproteome.
Tagliabracci VS; Wiley SE; Guo X; Kinch LN; Durrant E; Wen J; Xiao J; Cui J; Nguyen KB; Engel JL; Coon JJ; Grishin N; Pinna LA; Pagliarini DJ; Dixon JE
Cell; 2015 Jun; 161(7):1619-32. PubMed ID: 26091039
[TBL] [Abstract][Full Text] [Related]
4. A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins.
Cozza G; Salvi M; Banerjee S; Tibaldi E; Tagliabracci VS; Dixon JE; Pinna LA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1718-26. PubMed ID: 25936777
[TBL] [Abstract][Full Text] [Related]
5. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
6. Casein kinases as potential therapeutic targets.
Cozza G; Pinna LA
Expert Opin Ther Targets; 2016; 20(3):319-40. PubMed ID: 26565594
[TBL] [Abstract][Full Text] [Related]
7. Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4.
Zuo H; Yang D; Wan Y
Cancer Res; 2021 Oct; 81(20):5242-5254. PubMed ID: 34433585
[TBL] [Abstract][Full Text] [Related]
8. A secretory kinase complex regulates extracellular protein phosphorylation.
Cui J; Xiao J; Tagliabracci VS; Wen J; Rahdar M; Dixon JE
Elife; 2015 Mar; 4():e06120. PubMed ID: 25789606
[TBL] [Abstract][Full Text] [Related]
9. The Golgi 'casein kinase' Fam20C is a genuine 'phosvitin kinase' and phosphorylates polyserine stretches devoid of the canonical consensus.
Cozza G; Moro E; Black M; Marin O; Salvi M; Venerando A; Tagliabracci VS; Pinna LA
FEBS J; 2018 Dec; 285(24):4674-4683. PubMed ID: 30387551
[TBL] [Abstract][Full Text] [Related]
10. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of secretory pathway kinase Fam20C by site-1 protease promotes biomineralization.
Chen X; Zhang J; Liu P; Wei Y; Wang X; Xiao J; Wang CC; Wang L
Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34349020
[TBL] [Abstract][Full Text] [Related]
12. Ras-transformation reduce FAM20C expression and osteopontin phosphorylation.
Schytte GN; Christensen B; Bregenov I; Sørensen ES
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830861
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
[TBL] [Abstract][Full Text] [Related]
14. FAM20C directly binds to and phosphorylates Periostin.
Lin JH; Lin IP; Ohyama Y; Mochida H; Kudo A; Kaku M; Mochida Y
Sci Rep; 2020 Oct; 10(1):17155. PubMed ID: 33051588
[TBL] [Abstract][Full Text] [Related]
15. Knocking out FAM20C in pre-osteoblasts leads to up-regulation of osteoclast differentiation to affect long bone development.
Jiang L; Liu X; Liu L; Su L; Lu Z; Zhang H; Guo Y; Zhang W; Zhang S; Xu W; Zhang J; Zhang K; Zhan Y; Xie X; Li R; Dong X; Jin H; Zhang B; Li Y
Gene; 2024 Jul; 915():148396. PubMed ID: 38552750
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
18. The ABCs of the atypical Fam20 secretory pathway kinases.
Worby CA; Mayfield JE; Pollak AJ; Dixon JE; Banerjee S
J Biol Chem; 2021; 296():100267. PubMed ID: 33759783
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of triple-negative breast cancer cell growth by screening of a small-molecule library.
Fujita T; Mizukami T; Okawara T; Inoue K; Fujimori M
Breast Cancer; 2014 Nov; 21(6):738-47. PubMed ID: 23456737
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
